Robert Turcotte, MD, FRCS(C)

Clinical Interest  

Musculoskeletal Oncology

Current Appointments

Université McGill  /   McGill University
Professeur titulaire  /   Professor
Division de Chirurgie Orthopédique  / Division of Orthopaedic Surgery
Membre associé, Département d’Oncologie / Associate member, Department of Oncology

Centre universitaire de santé McGill-site HGM / McGill University Health Center-MGH Site
Department of Orthopaedic Surgery
Directeur medical, Programme suprarégional Sarcome / Medical director, Supraregional Sarcoma program 
Chef, Division d’oncologie chirurgicale  /  Head, Division of Surgical Oncology

Président, Association d'orthopédie du Québec / President, Quebec Orthopedic Association

Medical School

1977-1982    Université de Montréal

Residency

1982-1987    Édouard-Samson Orthopaedic Program, Université de Montréal

 

Fellowship

1988     Orthopaedic Oncology and Adult Reconstructive Surgery of the Lower Limb, Hôpital Cochin, Paris, France

1988-1989    Orthopaedic Oncology, Mayo Clinic, Rochester, MN

 

Grants Held in Last 5 Years

Source:
Title:
Applicant:
Amount/Term:

Mach Gaensslen Foundation of Canada
Myxoid Liposarcoma revisited
RE Turcotte, LC Moreau
$3360 / 2010

Source:
Title:
Applicant:
Amount/Term:

Public Health Agency of Canada and Quebec Ministry of Health and Social Affairs
Adverse effects following musculoskeletal allogenic tissue transplantation: a pilot study
RE Turcotte, P Robillard
$96,925 / 2009

Source:
Title:
Applicant:
Amount/Term:

Canadian Institute of Health Research (CIHR) (CTP-79857)
Molecular profiling of breast cancer metastases
P Siegel, RE Turcotte, V Ouellet
$30,000 / 2006-2011

Source:
Title:
Applicant:
Amount/Term:

Mach Gaensslen Foundation of Canada
Outcomes in recurrent soft tissue sarcoma
RE Turcotte, S Abatzoglou
$3360 / 2008

Source:
Title:
Applicant:
Amount/Term:

McGill University Health Centre Research Institute
Outcome in management of long bone metastases
RE Turcotte
$15,000 / 2008-2009

Source:
Title:

Applicant:
Amount/Term:

Howmedica Osteonics Corporation (Stryker Orthopaedics)
An in vivo evaluation of the effect of a hydroxyapatite coating with and without OP-1 on extracortical bone bridging using a canine segmental replacement model    
RE Turcotte
$58,526.52 / 2006-2007

Source:
Title:
Applicant:
Amount/Term:

Canadian Institute of Health Research (CRT-43818)
Interdisciplinary health research team in musculoskeletal neoplasia          
RE Turcotte
$71,000 / 2003-2007

 

Current Address

McGill University Health Centre 
Montreal General Hospital Site
1650 Cedar Avenue, #B5.159.4
Montreal, QC  H3G 1A4 

Telephone: (514) 934-1934 ext 42734
Fax: (514) 934-8453
robert [dot] turcotte [at] muhc [dot] mcgill [dot] ca

 

Recent Publications

Lu C, Jain SU, Hoelper D, Bechet D, Molden RC, Ran L, Murphy D, Venneti S, Hameed M, Pawel BR, Wunder JS, Dickson BC, Lundgren SM, Jani KS, De Jay N, Papillon-Cavanagh S, Andrulis IL, Sawyer SL, Grynspan D, Turcotte RE, Nadaf J, Fahiminiyah S, Muir TW, Majewski J, Thompson CB, Chi P, Garcia BA, Allis CD, Jabado N, Lewis PW. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape. Science. 2016 May 13;352(6287):844-9.

Stravropoulos N. Sawan H. Dandachli F. Turcotte R.E. The use of LARS tube in Stabilization of Proximal Humeral Endoprostheses. World J Orthop 2016 Apr; 7(4): 265- 271

Alicia Schiavi, Jacob Lavigne, Robert Turcotte, Lidia Kasprzak, Nadine Dumas, George Chong, Carolyn Freeman, Mona Alameldin, Polymnia Galiatsatos, Laura Palma, William D Foulkes. Using a family history questionnaire to identify patients at high risk for familial sarcoma. Current Onc 2015 Nov  22(5): 317-25

Nazarian A, Entezari V, Zurakowski D, Calderon N, Hipp J, Villa-Camacho J, Lin PP, Cheung F, Aboulafia A, Turcotte R, Anderson M, Gebhardt MC, Cheng EY, Terek RM, Yaszemski MJ, Damron T, Snyder B. Treatment Planning and Fracture Prediction in Patients with Skeletal Metastasis with CT2 based Rigidity Analysis. Clin Cancer Res. 2015 Jun 1;21(11):2514-9

Mak IW, Singh S, Turcotte R, Ghert M. The epigenetic regulation of SOX9 by miR-145 in human chondrosarcoma. J Cell Biochem. 2014 Aug 21. doi: 10.1002/jcb.24940. [Epub ahead of print]

Baroudi MR, Ferguson PC, Wunder JS, Isler MH, Mottard S, Werier JA, Turcotte RE. Forearm soft tissue sarcoma: Tumors characteristics and oncologic outcomes following limb salvage surgery. J Surg Oncol. 2014 Jun 9. 

Skamene SR, Rakheja R, Dalhstrom KR, Roberge D, Nahal A, Charest M, Turcotte R, Hickeson M, Freeman C. Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas. J Surg Oncol. 2013

Evidence for the Role of MMP-13 in Bone Resorption by Giant Cell Tumour of Bone. Mak I. Seidlitz EP. Cowan RW. Turcotte RE. Popovic S. Wu WCH. Singh G. Ghert M. Hum Pathol. 2010 Sep;41(9):1320-9.

High-speed burring with and without the use of chemical or thermal adjuvants in the intralesional management of Giant Cell Tumor of Bone: A systematic review and meta-analysis. H Algawahmed, R Turcotte, F Farrokhyar, M Ghert. (Sarcoma 2010)

Dedifferentiated giant cell tumor of bone in the form of low grade fibroblastic osteogenic sarcoma. A Ajlan, T Alcindor, R Turcotte, A Nahal. Curr Oncol. 2010 Aug;17(4):71-6.         

Local Recurrence After Initial Multidisciplinary Management of Soft Tissue Sarcoma: Is There a Way Out? Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D. Clin Orthop Relat Res. 2010 Nov;468(11):3012-8.

The efficacy of chemical adjuvants on giant-cell tumour of bone: An in vitro study. Gortzak, R. Kandel, B. Deheshi, J. Werier, R. E. Turcotte, P. C. Ferguson, and J. S. Wunder. J Bone Joint Surg Br 2010 92-B: 1475-1479.

Osteogenic Protein-1 Delivered by Hydroxyapatite-coated Implants Improves Bone Ingrowth in Extracortical Bone Bridging. Saran N, Turcotte RE, Zhang R. Clin Orthop Relat Res. 2010 Sep 28. [Epub ahead of print]